Propofol Ameliorates Exaggerated Human Neutrophil Activation in a LPS Sepsis Model

References

• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–211. doi:10.1016/S0140-6736(19)32989-7
   PubMed Web of Science ®Google Scholar
• Fleischmann C, Scherag A, Adhikari NKJ, et al. Assessment of global incidence and mortality of hospital-treated sepsis. current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259–272. doi:10.1164/rccm.201504-0781OC
   PubMed Web of Science ®Google Scholar
• Iwashyna TJ, Ely EW, Smith DM, et al. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304(16):1787–1794. doi:10.1001/jama.2010.1553
   PubMed Web of Science ®Google Scholar
• Vincent J-L, Marshall JC, Ñamendys-silva SA, et al. Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit. Lancet Respir Med. 2014;2(5):380–386. doi:10.1016/S2213-2600(14)70061-X
   PubMed Web of Science ®Google Scholar
• Matthay MA, Zemans RL, Zimmerman GA, et al. Acute respiratory distress syndrome. Nat Rev Dis Prim. 2019;5(1):18.
   PubMed Web of Science ®Google Scholar
• Skues MA, Prys-Roberts C. The pharmacology of propofol. J Clin Anesth. 1989;1(5):387–400. doi:10.1016/0952-8180(89)90080-9
   PubMedGoogle Scholar
• Sahinovic MM, Struys MMRF, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet. 2018;57(12):1539–1558. doi:10.1007/s40262-018-0672-3
   PubMed Web of Science ®Google Scholar
• Bateman BT, Kesselheim AS. Propofol as a transformative drug in anesthesia: insights from key early investigators. Drug Discov Today. 2015;20(8):1012–1017. doi:10.1016/j.drudis.2015.04.007
   PubMed Web of Science ®Google Scholar
• Fan W, Zhu X, Wu L, et al. Propofol: an anesthetic possessing neuroprotective effects. Eur Rev Med Pharmacol Sci. 2015;19(8):1520–1529.
   PubMed Web of Science ®Google Scholar
• Poffers M, Bühne N, Herzog C, et al. Sodium channel Nav1.3 is expressed by polymorphonuclear neutrophils during mouse heart and kidney ischemia in vivo and regulates adhesion, transmigration, and chemotaxis of human and mouse neutrophils in vitro. Anesthesiology. 2018;128(6):1151–1166. doi:10.1097/ALN.0000000000002135
   PubMed Web of Science ®Google Scholar
• Vasileiou I, Xanthos T, Koudouna E, et al. Propofol: a review of its non-anaesthetic effects. Eur J Pharmacol. 2009;605(1–3):1–8. doi:10.1016/j.ejphar.2009.01.007
   PubMed Web of Science ®Google Scholar
• Yang S-C, Chung P-J, Ho C-M, et al. Propofol inhibits superoxide production, elastase release, and chemotaxis in formyl peptide-activated human neutrophils by blocking formyl peptide receptor 1. J Immunol. 2013;190(12):6511–6519. doi:10.4049/jimmunol.1202215
   PubMed Web of Science ®Google Scholar
• Oliveira J, Reygaert WC. StatPearls: Gram Negative Bacteria. Treasure Island (FL): StatPearls Publishing; 2020.
   Google Scholar
• Auer GK, Weibel DB. Bacterial cell mechanics. Biochemistry. 2017;56(29):3710–3724. doi:10.1021/acs.biochem.7b00346
   PubMed Web of Science ®Google Scholar
• Livermore DM. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med. 2012;27(2):128–142. doi:10.3904/kjim.2012.27.2.128
   PubMed Web of Science ®Google Scholar
• Wang X, Quinn PJ. Endotoxins: lipopolysaccharides of gram-negative bacteria. Subcell Biochem. 2010;53:3–25.
   PubMedGoogle Scholar
• Tomar B, Anders H-J, Desai J, et al. Neutrophils and neutrophil extracellular traps drive necroinflammation in COVID-19. Cells. 2020;9(6):1383. doi:10.3390/cells9061383
   PubMed Web of Science ®Google Scholar
• Németh T, Sperandio M, Mócsai A. Neutrophils as emerging therapeutic targets. Nat Rev Drug Discov. 2020;19(4):253–275.
   PubMed Web of Science ®Google Scholar
• Kraus RF, Gruber MA, Kieninger M. The influence of extracellular tissue on neutrophil function and its possible linkage to inflammatory diseases. Immun Inflamm Dis. 2021. doi:10.1002/iid3.472
   PubMed Web of Science ®Google Scholar
• Bredthauer A, Kopfmueller M, Gruber M, et al. Therapeutic anticoagulation with argatroban and heparins reduces granulocyte migration: possible impact on ECLS-therapy? Cardiovasc Ther. 2020;2020:9783630. doi:10.1155/2020/9783630
   PubMed Web of Science ®Google Scholar
• Doblinger N, Bredthauer A, Mohrez M, et al. Impact of hydroxyethyl starch and modified fluid gelatin on granulocyte phenotype and function. Transfusion. 2019;59(6):2121–2130.
   PubMed Web of Science ®Google Scholar
• Pai D, Gruber M, Pfaehler S-M, et al. Polymorphonuclear cell chemotaxis and suicidal NETosis: simultaneous observation using fMLP, PMA, H7, and live cell imaging. J Immunol Res. 2020;2020:1–10. doi:10.1155/2020/1415947
   Web of Science ®Google Scholar
• Kolle G, Metterlein T, Gruber M, et al. Potential impact of local anesthetics inducing granulocyte arrest and altering immune functions on perioperative outcome. J Inflamm Res. 2021;14:1–12. doi:10.2147/JIR.S275525
   PubMed Web of Science ®Google Scholar
• Bitzinger DI, Schlachetzki F, Lindner R, et al. Flow-cytometric measurement of respiratory burst in rat polymorphonuclear granulocytes: comparison of four cell preparation procedures, and concentration-response evaluation of soluble stimulants. Cytometry A. 2008;73(7):643–650. doi:10.1002/cyto.a.20539
   PubMedGoogle Scholar
• Trabold B, Gruber M, Fröhlich D. Functional and phenotypic changes in polymorphonuclear neutrophils induced by catecholamines. Scandinavian Cardiovasc J. 2007;41(1):59–64. doi:10.1080/14017430601085948
   PubMed Web of Science ®Google Scholar
• Payen J-F, Chanques G, Futier E, et al. Sedation for critically ill patients with COVID-19: which specificities? One size does not fit all. Anaesth Crit Care Pain Med. 2020;39(3):341–343. doi:10.1016/j.accpm.2020.04.010
   PubMed Web of Science ®Google Scholar
• Chanques G, Constantin J-M, Devlin JW, et al. Analgesia and sedation in patients with ARDS. Intensive Care Med. 2020;46(12):2342–2356. doi:10.1007/s00134-020-06307-9
   PubMed Web of Science ®Google Scholar
• Khan MS, Zetterlund E-L, Gréen H, et al. Pharmacogenetics, plasma concentrations, clinical signs and EEG during propofol treatment. Basic Clin Pharmacol Toxicol. 2014;115(6):565–570. doi:10.1111/bcpt.12277
   PubMed Web of Science ®Google Scholar
• Chen M-S, Lin W-C, Yeh H-T, et al. Propofol specifically reduces PMA-induced neutrophil extracellular trap formation through inhibition of p-ERK and HOCl. Life Sci. 2019;221:178–186. doi:10.1016/j.lfs.2019.02.030
   PubMed Web of Science ®Google Scholar
• Thomson RJ, Hunter J, Dutton J, et al. Clinical characteristics and outcomes of critically ill patients with COVID-19 admitted to an intensive care unit in London: a prospective observational cohort study. PLoS One. 2020;15(12):e0243710. doi:10.1371/journal.pone.0243710
   PubMed Web of Science ®Google Scholar
• González-Correa JA, Cruz-Andreotti E, Arrebola MM, et al. Effects of propofol on the leukocyte nitric oxide pathway: in vitro and ex vivo studies in surgical patients. Naunyn Schmiedebergs Arch Pharmacol. 2008;376(5):331–339. doi:10.1007/s00210-007-0220-4
   PubMed Web of Science ®Google Scholar
• Lam C-F, Chang P-J, Chen Y-A, et al. Inhibition of ATP-sensitive potassium channels attenuates propofol-induced vasorelaxation. Crit Care Resusc. 2010;12(3):186–190.
   PubMed Web of Science ®Google Scholar
• Dominik S, Markus K, Kerstin L, et al. The mesenterially perfused rat small intestine: a versatile approach for pharmacological testings. Ann Anat. 2014;196(2–3):158–166. doi:10.1016/j.aanat.2014.02.008
   PubMed Web of Science ®Google Scholar
• Meier A, Chien J, Hobohm L, et al. Inhibition of human Neutrophil Extracellular Trap (NET) production by propofol and lipid emulsion. Front Pharmacol. 2019;10:323. doi:10.3389/fphar.2019.00323.
   PubMed Web of Science ®Google Scholar
• Nagata T, Kansha M, Irita K, et al. Propofol inhibits FMLP-stimulated phosphorylation of p42 mitogen-activated protein kinase and chemotaxis in human neutrophils. Br J Anaesth. 2001;86(6):853–858. doi:10.1093/bja/86.6.853
   PubMed Web of Science ®Google Scholar
• Kuroki M, O’Flaherty JT. Differential effects of a mitogen-activated protein kinase kinase inhibitor on human neutrophil responses to chemotactic factors. Biochem Biophys Res Commun. 1997;232(2):474–477. doi:10.1006/bbrc.1997.6296
   PubMed Web of Science ®Google Scholar
• Coffer PJ, Geijsen N, M’rabet L, et al. Comparison of the roles of mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function. Biochem J. 1998;329(Pt 1):121–130. doi:10.1042/bj3290121
   PubMedGoogle Scholar
• Sanders RD, Godlee A, Fujimori T, et al. Benzodiazepine augmented γ-amino-butyric acid signaling increases mortality from pneumonia in mice. Crit Care Med. 2013;41(7):1627–1636. doi:10.1097/CCM.0b013e31827c0c8d
   PubMed Web of Science ®Google Scholar
• Chen C-Y, Tsai Y-F, Huang W-J, et al. Propofol inhibits endogenous formyl peptide-induced neutrophil activation and alleviates lung injury. Free Radic Biol Med. 2018;129:372–382. doi:10.1016/j.freeradbiomed.2018.09.048
   PubMed Web of Science ®Google Scholar
• Fuchs TA, Abed U, Goosmann C, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007;176(2):231–241. doi:10.1083/jcb.200606027
   PubMed Web of Science ®Google Scholar
• Yousefi S, Mihalache C, Kozlowski E, et al. Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ. 2009;16(11):1438–1444. doi:10.1038/cdd.2009.96
   PubMed Web of Science ®Google Scholar
• Wiedermann CJ, Kiechl S, Dunzendorfer S, et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease. J Am Coll Cardiol. 1999;34(7):1975–1981. doi:10.1016/S0735-1097(99)00448-9
   PubMed Web of Science ®Google Scholar
• Opal SM, Scannon PJ, Vincent JL, et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis. 1999;180(5):1584–1589. doi:10.1086/315093
   PubMed Web of Science ®Google Scholar
• Wang X, Qin W, Zhang Y, et al. Endotoxin promotes neutrophil hierarchical chemotaxis via the p38-membrane receptor pathway. Oncotarget. 2016;7(45):74247–74258. doi:10.18632/oncotarget.12093
   PubMedGoogle Scholar
• Wang X, Qin W, Xu X, et al. Endotoxin-induced autocrine ATP signaling inhibits neutrophil chemotaxis through enhancing myosin light chain phosphorylation. Proc Natl Acad Sci U S A. 2017;114(17):4483–4488. doi:10.1073/pnas.1616752114
   PubMed Web of Science ®Google Scholar
• Khan AI, Heit B, Andonegui G, et al. Lipopolysaccharide: a p38 MAPK-dependent disrupter of neutrophil chemotaxis. Microcirculation. 2005;12(5):421–432. doi:10.1080/10739680590960368
   PubMed Web of Science ®Google Scholar
• Zhu L, Liu L, Zhang Y, et al. High level of neutrophil extracellular traps correlates with poor prognosis of severe influenza a infection. J Infect Dis. 2018;217(3):428–437. doi:10.1093/infdis/jix475
   PubMed Web of Science ®Google Scholar
• Saksena S, Chattopadhyay P. Illuminating the immunopathology of SARS-CoV-2. Cytometry B Clin Cytom. 2021;100(1):33–41. doi:10.1002/cyto.b.21988
   PubMed Web of Science ®Google Scholar
• Borges L, Pithon-Curi TC, Curi R, et al. COVID-19 and neutrophils: the relationship between hyperinflammation and neutrophil extracellular traps. Mediators Inflamm. 2020;2020:8829674. doi:10.1155/2020/8829674
   PubMed Web of Science ®Google Scholar